Ellie Collins

The desire to make a difference in the world is at the heart of everything we do at Oxford PharmaGenesis.

Oxford PharmaGenesis recently attended the 8th annual World Orphan Drug Congress (WODC) in Barcelona, which highlighted the importance of early and effective collaboration and communication between patients and other healthcare stakeholders, particularly in the rare disease space.

We were busy at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress in Glasgow last month.

It’s hard to believe that it’s only 12 months since Oxford PharmaGenesis officially launched its Patient Engagement Practice at the 2016 eyeforpharma Patient Summit.

Oxford PharmaGenesis, Inc. has been certified a ‘Great Place to Work’ by a leading global authority on high-performing workplace cultures.

On Friday 8 September, representatives from patient organizations and pharmaceutical companies gathered at the Royal Society in London to attend the workshop ‘Working with industry’, which was run by Findacure.

Oxford PharmaGenesis is thrilled to announce the expansion of our global presence with the opening of a new office in Melbourne, Australia.

After celebrating the opening of our temporary Oxford city centre office at the end of last year, we are pleased to announce that it has moved to its official home, right in the heart of the action.

Over 60 members of staff from an Oxford-based international HealthScience communications consultancy are walking 1 million steps over 3 months in an effort to raise funds for leading charity Diabetes UK.

On Sunday 9 July, Oxford PharmaGenesis Commercial Director Dr Richard White completed the Velothon Wales bike race in support of Ataxia and Me, a rare disease charity run by Alan Thomas.